Open AccessPredictors of efficacy of corticosteroid switching from abiraterone plus prednisone to dexamethasone in patients with metastatic castration-resistant prostate cancer
Author(s) -
Yang Ni,
Jinge Zhao,
Mengni Zhang,
Yijun Zhang,
Zhenyu Yang,
Ni Chen,
JunRu Chen,
Pengfei Shen,
Guangxi Sun,
Xingming Zhang,
Yonghong Li,
Hao Zeng
Publication year - 2022
Publication title -
asian journal of andrology/asian journal of andrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 74
eISSN - 1745-7262
pISSN - 1008-682X
DOI - 10.4103/aja202143
Subject(s) - abiraterone acetate , medicine , prostate cancer , prednisone , corticosteroid , hazard ratio , urology , dexamethasone , gastroenterology , confidence interval , cancer , androgen deprivation therapy